Skip to main content
# Title Department Research Year
721 Simultaneous TLC-Densitometric Determination of Tamoxifen Citrate and Medroxyprogesterone Acetate and UV-Degradation Kinetic Study of Medroxyprogesterone Acetate Department of Pharmaceutical Analytical Chemistry 2018
722 Innovative HPTLC Method with Fluorescence Detection for Assessment of Febuxostat-Montelukast Combination and Study of Their Protective Effects Against Gouty Arthritis 2018
723 A rapid Fourier transform infrared spectroscopic method for analysis of certain proton pump inhibitors in binary and ternary mixtures Department of Pharmaceutical Analytical Chemistry 2018
724 Novel N-Substituted 5-aminosalicylamides as Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase Enzymes: Synthesis, Biological Evaluation and Docking Study 2018
725 Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits Department of Pharmaceutical Analytical Chemistry 2018
726 Glibenclamide Mini-tablets with an Enhanced Pharmacokinetic and Pharmacodynamic Performance Department of Industrial Pharmacy 2018
727 Efficient HPTLC-dual wavelength spectrodensitometric method for simultaneous determination of sofosbuvir and daclatasvir: Biological and pharmaceutical analysis Department of Pharmaceutical Analytical Chemistry 2018
728 Enhanced dispersive solid phase extraction assisted by cloud point strategy prior to fluorometric determination of anti-hepatitis C drug velpatasvir in pharmaceutical tablets and body fluids Department of Pharmaceutical Analytical Chemistry 2018
729 Fluorimetric determination of febuxostat in dosage forms and in real human plasma via Förster resonance energy transfer‏ Department of Pharmaceutical Analytical Chemistry 2018
730 Ultrasensitive Spectrofluorimetric Method for Rapid Determination of Daclatasvir and Ledipasvir in Human Plasma and Pharmaceutical Formulations Department of Pharmaceutical Analytical Chemistry 2018